Contact this trialFirst, we need to learn more about you.
Procedure
TL-925 for Allergic Conjunctivitis
Recruiting0 awardsPhase 2
Andover, Massachusetts
This trial studies a drug (TL-925) to treat allergic conjunctivitis. 70 people will get the drug or a placebo and be monitored for effectiveness.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.